Advertisement

Chinese Science Bulletin

, Volume 53, Issue 13, pp 2008–2016 | Cite as

Human RBCs blood group conversion from A to O using a novel α-N-acetylgalactosaminidase of high specific activity

  • ChengYu Yu
  • Hua Xu
  • LiSheng Wang
  • JianGeng Zhang
  • YangPei Zhang
Articles Medical Biochemistry

Abstract

α-N-acetylgalactosaminidase (αNAGA) can convert group A human red blood cells (RBCs) to group O. One novel αNAGA gene was cloned by PCR from Elizabethkingia meningosepticum isolated from a domestic clinical sample. Pure recombinant αNAGA was obtained by genetic engineering and protein purification with a calculated molecule of 49.6 kD. αNAGA was selective for terminal α-N-acetylgalactosamine residue with a high specific activity. αNAGA could completely remove A antigens of 1 U (about 100 mL) group A1 or A2 RBCs in 1 h at pH 6.8 and 25°C with a consumption of 1.5 or 0.4 mg recombinant enzyme. Enzyme-converted group A RBCs did not agglutinate after being mixed with monoclonal anti-A or sera of groups A, B, AB and O. Other blood group antigens except ABO had no change. FCM analysis showed that A antigens and A1 antigens disappeared while H antigens increased. It indicated that αNAGA successfully converted human blood group A RBCs to universally transfusable group O RBCs without the risk of ABO-incompatible transfusion reactions. This αNAGA was suitable for producing universal RBCs to increase clinical transfusion safety, improve the RBCs supply, and to decrease transfusion cost and support transfusion service in case of emergency.

Keywords

universal RBCs blood group conversion α-N-acetylgalactosaminidase transfusion A antigen A1 antigen 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Goodnough L T, Shander A, Brecher M E. Transfusion medicine: Looking to the future. Lancet, 2003, 361(9352): 161–169PubMedCrossRefGoogle Scholar
  2. 2.
    Garratty G. Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs. Transfus Med Rev, 2004, 18(4): 245–256PubMedCrossRefGoogle Scholar
  3. 3.
    Olsson M L, Hill C A, de la Vega H, et al. Universal red blood cells—enzymatic conversion of blood group A and B antigens. Transfus Clin Biol, 2004, 11(1): 33–39PubMedCrossRefGoogle Scholar
  4. 4.
    Garratty G. Modulating the red cell membrane to produce universal/stealth donor red cells suitable for transfusion. Vox Sang. 2008, 94(2): 87–95PubMedGoogle Scholar
  5. 5.
    Goldstein J, Siviglia G, Hurst R, et al. Group B erythrocytes enzymatically converted to group O survive normally in A, B and O individuals. Science, 1982, 215: 168–170PubMedCrossRefGoogle Scholar
  6. 6.
    Lenny L L, Hurst R, Goldstein J, et al. Single-unit transfusions of RBC enzymatically converted from group B to group O to A and O normal volunteers. Blood. 1991, 77(6): 1383–1388PubMedGoogle Scholar
  7. 7.
    Zhu A, Leng L, Monahan C, et al. Characterization of recombinant alpha-galactosidase for use in seroconversion from blood group B to O of human crythrocytes. Arch Biochem Biophys, 1996, 327(2): 324–329PubMedCrossRefGoogle Scholar
  8. 8.
    Zhu A, Monahan C, Wang Z K, et al. Expression, purification, and characterization of recombinant alpha-N-acetylgalactosaminidase produced in the yeast Pichia pastoris. Protein Expr Purif, 1996, 8: 456–462PubMedCrossRefGoogle Scholar
  9. 9.
    Davis M O, Hata D J, Smith D, et al. Cloning and sequence of a chicken alpha-N-acetylgalactosaminidase gene. Biochim Biophys Acta, 1993, 1216(2): 296–298PubMedGoogle Scholar
  10. 10.
    Herrmann T, Schindler D, Tabe H, et al. Molecular cloning, structural organization, sequence, chromosomal assignment, and expression of the mouse alpha-N-acetylgalactosaminidase gene. Gene, 1998, 211(2): 205–214PubMedCrossRefGoogle Scholar
  11. 11.
    Borzova N V, Varbanets L D. Aspergillus niger alpha-N-acetylgalactosaminidase: isolation, purification and properties. Ukr Biokhim Zh, 2006, 78(5): 29–43PubMedGoogle Scholar
  12. 12.
    Hsin-Yeh H, Chapman L F, Calcutt M J, et al. Recombinant Clostridium perfringens alpha-N-acetylgalactosaminidase blood group A2 degrading activity. Artif Cells Blood Substit Immobil Biotechnol, 2005, 33(2): 187–199PubMedCrossRefGoogle Scholar
  13. 13.
    Anderson K M, Ashida H, Maskos K, et al. A clostridial endo-beta-galactosidase that cleaves both blood group A and B glycotopes: The first member of a new glycoside hydrolase family, GH98. J Biol Chem, 2005, 280(9): 7720–7728PubMedCrossRefGoogle Scholar
  14. 14.
    Landry D. Isolation and composition of a novel glycosidase from chryseobacterium. US Patent, 6458573, 2002-10-1Google Scholar
  15. 15.
    Liu Q P, Sulzenbacher G, Yuan H, et al. Bacterial glycosidases for the production of universal red blood cells. Nat Biotechnol, 2007, 25(4): 454–464PubMedCrossRefGoogle Scholar
  16. 16.
    Qiu Yan. Quality and standardization of full blood and component. Beijing: Chinese Standard Press, 2003, 18–31Google Scholar
  17. 17.
    Daniels G, Withers S G. Towards universal red blood cells. Nat Biotechnol, 2007, 25(4): 427–428PubMedCrossRefGoogle Scholar
  18. 18.
    Olsson M L, Clausen H. Modifying the red cell surface: towards an ABO-universal blood supply. Br J Haematol, 2008, 140(1): 3–12PubMedGoogle Scholar
  19. 19.
    Zhang Yangpei, Yang Jun, Gao Xin, et al. Blood group conversion from B to O using recombinant α-galactosidase. Chin Sci Bull, 2003, 48: 43–47Google Scholar
  20. 20.
    Zhang Y P, Gong F, Bao G Q, et al. B to O erythrocyte conversion by the recombinant alpha-galactosidase. Chin Med J (Engl), 2007, 120: 1145–1150Google Scholar

Copyright information

© Science in China Press and Springer-Verlag GmbH 2008

Authors and Affiliations

  • ChengYu Yu
    • 1
  • Hua Xu
    • 2
  • LiSheng Wang
    • 3
  • JianGeng Zhang
    • 2
  • YangPei Zhang
    • 1
  1. 1.Department of Blood Molecular Biology, Institute of Military TransfusionAcademy of Military Medical ScienceBeijingChina
  2. 2.Shaanxi Blood CentreXi’anChina
  3. 3.Department of Experimental Hematology, Institute of Radiation MedicineAcademy of Military Medical ScienceBeijingChina

Personalised recommendations